Cantor raises PFE, LLY, MRK price targets, flags Pfizer growth concerns

Cantor Fitzgerald lifted price targets on Pfizer, Eli Lilly and Merck, citing upcoming trial results and earnings expectations, while flagging growth concerns for Pfizer.